
Rainbow Childrens Medicare Q1 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- Revenue for Q1 FY2024 grew by 21% to Rs.287.1 Crores driven by higher delivery numbers, pediatric surgical cases, and addition of 155 beds in 2 units.
- Outpatient and inpatient volumes increased by 11.6% and 13.9% respectively compared to FY2022.
- Occupancy in mature hospitals was robust at 47.6%, with new hospitals at 28.1%, expected to improve as they mature.
- Expansion plan includes adding 270 beds across locations, including new outpatient block with IVF facility in Hyderabad, and 60 beds in central Hyderabad.
- New hospitals in Bengaluru and Chennai expected to become EBITDA positive soon, with spoke models taking 12-18 months to mature.
- ARPOB growth is expected around 5-6% annually assuming stable average length of stay.
- International business targeted to grow to 4% of overall business.
- Management remains positive on project execution and operational growth for the year.
See what Rainbow Childrens Medicare management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No explicit mention of any current or planned fundraising through debt or equity in the provided transcript.
- The company has a strong cash and cash equivalent position of Rs. 474.2 Crores as of June 30, 2023, which includes Rs. 130 Crores from IPO funds.
- Management expressed confidence in completing all planned capital expenditure (capex) of roughly Rs. 800-900 Crores over the next four years using internal accruals plus the existing cash balance.
- Annual capex is expected to be between Rs. 200 to 225 Crores in the near term.
- There are no indications of plans to raise new debt or equity; the company aims to remain cash positive throughout its expansion.
- The management emphasized reliance on internal cash generation and existing cash reserves without stating any need for fresh fundraising.
See what Rainbow Childrens Medicare management said on order book — free account, 30 seconds.
Capex plans
Yes- Rainbow Children’s Medicare Limited plans to build roughly 930 beds over the next 4 years, with an overall capex of approximately Rs. 800 to 900 Crores, including the Gurugram land parcel.
- As of June 30, 2023, the company holds Rs.474 Crores cash, including Rs.130 Crores IPO funds, supporting the capex plan.
- Annual capex for FY2024 is expected to be between Rs. 200 to 225 Crores, higher than previous years due to opening 4 hospitals this year and 2 next year.
- Routine capex is modest, around Rs. 20 to 25 Crores annually; the majority of expenditure is on new projects.
- The capex spend is spread over the next four years, including the balance of the current year.
- The company remains confident of being cash positive after completing all announced capex plans through internal accruals and existing cash reserves.
Track Rainbow Childrens Medicare — get its next earnings analysis in your feed
How does Rainbow Childrens Medicare rank vs peers in Healthcare Services?
Pro featureHow does Rainbow Childrens Medicare rank in Healthcare Services?
Compare Rainbow Childrens Medicare against every Healthcare Services company (Q1 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Rainbow Childrens Medicare's management said in earlier quarters
Others in Healthcare Services this season
- Chandan Healthca (Q2 FY27)
Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor
- Invicta Diagnostic (Q2 FY27)
Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2
- Unihealth Hosp (Q2 FY27)
1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r
- Sangani Hospital (Q2 FY27)
1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.